Dudediligence.

Viking Therapeutics, Inc

VKTXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$22.3M

11 notices · 664,041 sh

Oct 2025 to Oct 2026

Reported ·

$16.0M

17 sales · 1 buy · $149,913 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 17 reported sales carry the 10b5-1 box. Together they are 0.41% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-07-29: BRIAN LIAN, Form 1442026-07-29: GREG ZANTE, Form 1442026-07-29: MARIANNA MANCINI, Form 1442026-01-05: MARIANNA MANCINI, Form 1442026-01-05: GREG ZANTE, Form 1442026-01-05: BRIAN LIAN, Form 1442026-01-02: MATTHEW W. FOEHR, Form 1442025-10-28: GREG ZANTE, Form 1442025-10-28: MARIANNA MANCINI, Form 1442025-10-28: BRIAN LIAN, Form 1442025-10-27: CHARLES A ROWLAND JR., Form 1442025-10-27: Rowland Charles A Jr, sold2025-10-28: ZANTE GREG, sold2025-10-28: Lian Brian, sold2025-10-28: Mancini Marianna, sold2026-01-02: FOEHR MATTHEW W, sold2026-01-05: Lian Brian, sold2026-01-05: Mancini Marianna, sold2026-01-05: ZANTE GREG, sold2026-03-10: Aubuchon Neil William, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-07-29BRIAN LIAN, President & CEO$4,947,888
148,517 shplan 2026-01-15Form 4s on file end Jun 23144 ↗
2026-07-29GREG ZANTE, Chief Financial Officer$710,141
21,217 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-29MARIANNA MANCINI, Chief Operating Officer$609,636
18,217 shno plan dateForm 4s on file end Jun 23144 ↗
2026-01-05MARIANNA MANCINI, Chief Operating Officer$1,901,406
57,661 shno plan date144 ↗
Form 4, 2026-01-05: sold 57,661 at $32.97 Form 4 ↗
2026-01-05GREG ZANTE, Chief Financial Officer$1,901,470
57,661 shno plan date144 ↗
Form 4, 2026-01-05: sold 57,661 at $32.90 Form 4 ↗
2026-01-05BRIAN LIAN, President & CEO$7,692,134
233,409 shno plan date144 ↗
Form 4, 2026-01-05: sold 233,409 at $32.96 Form 4 ↗
2026-01-02MATTHEW W. FOEHR, Director$561,694
16,000 shno plan date144 ↗
Form 4, 2026-01-05: sold 16,000 at $35.11 Form 4 ↗
2025-10-28GREG ZANTE, Chief Financial Officer$216,531
6,185 shno plan date144 ↗
Form 4, 2025-10-28: sold 6,185 at $35.00 Form 4 ↗
2025-10-28MARIANNA MANCINI, Chief Operating Officer$216,492
6,185 shno plan date144 ↗
Form 4, 2025-10-28: sold 6,185 at $35.00 Form 4 ↗
2025-10-28BRIAN LIAN, President & CEO$1,364,923
38,989 shno plan date144 ↗
Form 4, 2025-10-28: sold 38,989 at $35.01 Form 4 ↗
2025-10-27CHARLES A ROWLAND JR., Director$2,134,278
60,000 shno plan date144 ↗
Form 4, 2025-10-28: sold 60,000 at $35.57 Form 4 ↗